{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T19:37:46Z","timestamp":1783366666295,"version":"3.54.6"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"21","license":[{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Purpose<\/jats:title>\n                  <jats:p>We report the case of a 2-year-old girl with end-stage renal disease managed by peritoneal dialysis (PD) who developed methicillin-resistant staphylococcal osteomyelitis of the left shoulder and was successfully treated with intraperitoneal (IP) administration of vancomycin for 2 weeks followed by oral clindamycin therapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Summary<\/jats:title>\n                  <jats:p>The patient was hospitalized with tactile fever and a 3-day history of worsening fussiness. Radiography of the left shoulder showed findings indicative of osteomyelitis. Vancomycin was administered via central venous line for 3 days, during which time the patient underwent PD 24 hours a day. After magnetic resonance imaging revealed proximal humeral osteomyelitis, septic arthritis of the shoulder joint, and osteomyelitis of the scapula, the patient underwent incision and drainage of the left shoulder joint. Both blood and joint drainage cultures grew methicillin-resistant Staphylococcus aureus that was sensitive to vancomycin. The patient\u2019s central venous catheter was removed on hospital day 4; due to difficulties with peripheral i.v. access and a desire to avoid placing a peripherally inserted central venous catheter, vancomycin administration was changed to the IP route, with vancomycin added to the PD fluid. During IP treatment, serum vancomycin levels were maintained at 13.5 to 18.5 mg\/L, and the calculated ratio of vancomycin area under the curve to minimum inhibitory concentration was maintained above 400. After completing a 14-day course of IP vancomycin therapy, the patient was switched to oral clindamycin, with subsequent complete resolution of osteomyelitis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>IP vancomycin was effective for treatment of invasive S. aureus infection in this case. This approach should be considered in patients undergoing PD for whom peripheral i.v. access options are limited and\/or not preferred.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajhp\/zxaa244","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T05:14:10Z","timestamp":1599801250000},"page":"1746-1750","source":"Crossref","is-referenced-by-count":6,"title":["Intraperitoneal vancomycin treatment of multifocal methicillin-resistant <i>Staphylococcus aureus<\/i> osteomyelitis in a patient on peritoneal dialysis"],"prefix":"10.1093","volume":"77","author":[{"given":"Qassim","family":"Abid","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Wayne State University, Detroit, MI"},{"name":"Division of Nephrology and Hypertension, Children\u2019s Hospital of Michigan, Detroit, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basim","family":"Asmar","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Wayne State University, Detroit, MI"},{"name":"Division of Infectious Diseases, Children\u2019s Hospital of Michigan, Detroit, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Wayne State University, Detroit, MI"},{"name":"Division of Infectious Diseases, Children\u2019s Hospital of Michigan, Detroit, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Molloy","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Children\u2019s Hospital of Michigan, Detroit, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Gregory","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Wayne State University, Detroit, MI"},{"name":"Division of Nephrology and Hypertension, Children\u2019s Hospital of Michigan, Detroit, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolph P","family":"Valentini","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Wayne State University, Detroit, MI"},{"name":"Division of Nephrology and Hypertension, Children\u2019s Hospital of Michigan, Detroit, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,9,11]]},"reference":[{"key":"2020120619313652300_CIT0001","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11908-002-0012-4","article-title":"Long bone osteomyelitis","volume":"4","author":"Lazzarini","year":"2002","journal-title":"Curr Infect Dis Rep"},{"key":"2020120619313652300_CIT0002","first-page":"306","article-title":"The 3 types of acute hematogenous osteomyelitis","volume":"93","author":"Trueta","year":"1963","journal-title":"Schweiz Med Wochenschr."},{"issue":"3","key":"2020120619313652300_CIT0003","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/QCO.0b013e3283005441","article-title":"Acute haematogenous osteomyelitis in children: is there any evidence for how long we should treat?","volume":"21","author":"Weichert","year":"2008","journal-title":"Curr Opin Infect Dis."},{"key":"2020120619313652300_CIT0004","volume-title":"Tachdjian\u2019s Pediatric Orthopaedics: From the Texas Scottish Rite Hospital for Children","author":"Herring","year":"2014"},{"issue":"3","key":"2020120619313652300_CIT0005","doi-asserted-by":"crossref","first-page":"166","DOI":"10.5435\/00124635-200105000-00003","article-title":"Acute hematogenous osteomyelitis in children","volume":"9","author":"Song","year":"2001","journal-title":"J Am Acad Orthop Surg."},{"key":"2020120619313652300_CIT0006","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1086\/507637","article-title":"Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection","volume":"43","author":"Pannaraj","year":"2006","journal-title":"Clin Infect Dis."},{"issue":"2","key":"2020120619313652300_CIT0007","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-0029-1214160","article-title":"Radiographic imaging in osteomyelitis: the role of plain radiography, computed tomography, ultrasonography, magnetic resonance imaging, and scintigraphy","volume":"23","author":"Pineda","year":"2009","journal-title":"Semin Plast Surg."},{"key":"2020120619313652300_CIT0008","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00247-008-0888-8","article-title":"Optimal imaging strategy for community-acquired Staphylococcus aureus musculoskeletal infections in children","volume":"38","author":"Browne","year":"2008","journal-title":"Pediatr Radiol."},{"issue":"8","key":"2020120619313652300_CIT0009","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/01.inf.0000078901.26909.cf","article-title":"Culture-negative osteomyelitis","volume":"22","author":"Floyed","year":"2003","journal-title":"Pediatr Infect Dis J."},{"issue":"7","key":"2020120619313652300_CIT0010","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/BPO\/0b013e3181558981","article-title":"What would pediatric infectious disease consultants recommend for management of culture-negative acute hematogenous osteomyelitis?","volume":"27","author":"Afghani","year":"2007","journal-title":"J Pediatr Orthop."},{"issue":"3","key":"2020120619313652300_CIT0011","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2020120619313652300_CIT0012","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1001\/jamapediatrics.2014.2822","article-title":"Comparative effectiveness of intravenous vs oral antibiotics for postdischarge treatment of acute osteomyelitis in children","volume":"169","author":"Keren","year":"2015","journal-title":"JAMA Pediatr"},{"issue":"3","key":"2020120619313652300_CIT0013","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1093\/jpids\/pix014","article-title":"Clinical care guideline for improving pediatric acute musculoskeletal infection outcomes","volume":"6","author":"Spruiell","year":"2017","journal-title":"J Pediatric Infect Dis Soc"},{"key":"2020120619313652300_CIT0014","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2146\/ajhp080434","article-title":"Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists","volume":"66","author":"Rybak","year":"2009","journal-title":"Am J Health-Syst Pharm."},{"key":"2020120619313652300_CIT0015","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.3747\/pdi.2011.00091","article-title":"Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update","volume":"32","author":"Warady","year":"2012","journal-title":"Perit Dial Int"},{"issue":"2","key":"2020120619313652300_CIT0016","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1128\/AAC.31.2.173","article-title":"Comparative study of intraperitoneal and intravenous vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis","volume":"31","author":"Morse","year":"1987","journal-title":"Antimicrob Agents Chemother."},{"issue":"1","key":"2020120619313652300_CIT0017","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/089686080702700117","article-title":"Vancomycin disposition following intraperitoneal administration in children receiving peritoneal dialysis","volume":"27","author":"Blowey","year":"2007","journal-title":"Perit Dial Int."},{"issue":"4","key":"2020120619313652300_CIT0018","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1128\/AAC.27.4.578","article-title":"Vancomycin disposition during continuous ambulatory peritoneal dialysis: a pharmacokinetic analysis of peritoneal drug transport","volume":"27","author":"Rogge","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"2020120619313652300_CIT0019","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3747\/pdi.2016.00078","article-title":"ISPD peritonitis recommendations: 2016 updated on prevention and treatment","volume":"36","author":"Li","year":"2016","journal-title":"Perit Dial Int"},{"key":"2020120619313652300_CIT0020","first-page":"S1","article-title":"KDOQI clinical practice guidelines and clinical practice recommendations for 2006 updates: hemodialysis adequacy, peritoneal dialysis adequacy and vascular access","volume":"48","author":"National Kidney Foundation","year":"2006","journal-title":"Am J Kidney Dis."},{"issue":"24","key":"2020120619313652300_CIT0021","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.2146\/ajhp180034","article-title":"Making the change to area under the curve\u2013based vancomycin dosing","volume":"75","author":"Heil","year":"2018","journal-title":"Am J Health-Syst Pharm"},{"issue":"1","key":"2020120619313652300_CIT0022","first-page":"41","article-title":"Vancomycin AUC\/MIC and corresponding troughs in a pediatric population","volume":"22","author":"Kishk","year":"2017","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"5","key":"2020120619313652300_CIT0023","doi-asserted-by":"crossref","first-page":"e02535","DOI":"10.1128\/AAC.02535-16","article-title":"Establishment of an AUC0\u201324 threshold for nephrotoxicity is a step towards individualized vancomycin dosing for methicillin resistant Staphylococcus aureus bacteremia","volume":"61","author":"Chavada","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2020120619313652300_CIT0024","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/clpt.1983.225","article-title":"Vancomycin kinetics during continuous ambulatory peritoneal dialysis","volume":"34","author":"Bunke","year":"1983","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"2020120619313652300_CIT0025","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/AAC.25.5.603","article-title":"Pharmacokinetics of vancomycin in patients undergoing continuous ambulatory peritoneal dialysis","volume":"25","author":"Blevins","year":"1984","journal-title":"Antimicrob Agents Chemother"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/77\/21\/1746\/34499123\/zxaa244.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/77\/21\/1746\/34499123\/zxaa244.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T02:46:36Z","timestamp":1607309196000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/77\/21\/1746\/5903950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,11]]},"references-count":25,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2020,9,11]]},"published-print":{"date-parts":[[2020,10,14]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxaa244","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,11,1]]},"published":{"date-parts":[[2020,9,11]]}}}